Roberto, M.; Romiti, A.; Mazzuca, F.; Milano, A.; D’Antonio, C.; Lionetto, L.; Falcone, R.; Strigari, L.; Simmaco, M.; Fais, S.;
et al. Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial. Cancers 2020, 12, 3084.
https://doi.org/10.3390/cancers12113084
AMA Style
Roberto M, Romiti A, Mazzuca F, Milano A, D’Antonio C, Lionetto L, Falcone R, Strigari L, Simmaco M, Fais S,
et al. Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial. Cancers. 2020; 12(11):3084.
https://doi.org/10.3390/cancers12113084
Chicago/Turabian Style
Roberto, Michela, Adriana Romiti, Federica Mazzuca, Annalisa Milano, Chiara D’Antonio, Luana Lionetto, Rosa Falcone, Lidia Strigari, Maurizio Simmaco, Stefano Fais,
and et al. 2020. "Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial" Cancers 12, no. 11: 3084.
https://doi.org/10.3390/cancers12113084
APA Style
Roberto, M., Romiti, A., Mazzuca, F., Milano, A., D’Antonio, C., Lionetto, L., Falcone, R., Strigari, L., Simmaco, M., Fais, S., & Marchetti, P.
(2020). Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial. Cancers, 12(11), 3084.
https://doi.org/10.3390/cancers12113084